[Federal Register Volume 81, Number 74 (Monday, April 18, 2016)]
[Notices]
[Page 22638]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-08844]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Registration: Meridian Medical 
Technologies

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Meridian Medical Technologies applied to be registered as an 
importer of a certain basic class of controlled substance. The Drug 
Enforcement Administration (DEA) grants Meridian Medical Technologies 
registration as an importer of this controlled substance.

SUPPLEMENTARY INFORMATION: By notice dated November 27, 2015, and 
published in the Federal Register on December 3, 2015, 80 FR 75691, 
Meridian Medical Technologies, 2555 Hermelin Drive, Saint Louis, 
Missouri 63144 applied to be registered as an importer of a certain 
basic class of controlled substance. No comments or objections were 
submitted for this notice.
    The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 
958(a) and determined that the registration of Meridian Medical 
Technologies to import the basic class of controlled substance is 
consistent with the public interest and with United States obligations 
under international treaties, conventions, or protocols in effect on 
May 1, 1971. The DEA investigated the company's maintenance of 
effective controls against diversion by inspecting and testing the 
company's physical security systems, verifying the company's compliance 
with state and local laws, and reviewing the company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the above-named company is granted 
registration as an importer of morphine (9300), a basic class of 
controlled substance listed in schedule II.
    The company manufactures a product containing morphine in the 
United States. The company exports this product to customers around the 
world. The company has been asked to ensure that its product, which is 
sold to European customers, meets the standards established by the 
European Pharmacopeia, administered by the Directorate for the Quality 
of Medicines (EDQM). In order to ensure that its product will meet 
European specifications, the company seeks to import morphine supplied 
by EDQM for use as reference standards.
    This is the sole purpose for which the company will be authorized 
by the DEA to import morphine.

    Dated: April 11, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016-08844 Filed 4-15-16; 8:45 am]
 BILLING CODE 4410-09-P